胰腺癌临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 胰腺癌（国际通用名 pancreatic cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖胰癌等说法。

正在招募的胰腺癌新药试验

• A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals

  不适用招募中美国NCT03250078

• Delayed Gastric Emptying After Pancreatic Surgery

  不适用招募中中国台湾NCT07382791

• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  I 期 / II 期招募中美国日本NCT07488676

• Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

  不适用招募中法国NCT06649474

• Adebrelimab and Chidamide for Pancreatic Cancer

  II 期招募中中国NCT06584227

• A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

  II 期招募中中国NCT05859750

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  I 期 / II 期招募中美国法国西班牙英国NCT04657068

• A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer

  II 期 / III 期招募中美国NCT06079346

• Role of Genetic Factors in the Development of Lung Disease

  不适用招募中美国NCT00001532

• A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  II 期招募中美国澳大利亚加拿大中国NCT06760819

• Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE

  不适用招募中中国NCT06849063

• Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  I 期招募中美国NCT06218914